Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01403688 · ClinicalTrials.gov registry record
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin
A clinical trial, sponsored by University of Kansas.
- Completed
- Registry status
- 9
- Enrollment target
NCT01403688 is a clinical trial that has completed, run by University of Kansas. The registered enrollment target is 9 participants.
The verdict
NCT01403688 has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Fertility drugs have the effect of increasing hormone levels. Higher hormone levels from infertility treatments may increase breast cancer risk, but there has not been enough research to know for sure. Researchers want to use a method of taking breast tissue cells from women who are having infertility treatment. The breast tissue cells might show changes that would indicate an increased risk of cancer. The method of taking the breast tissue cells is called Fine Needle Aspiration (FNA). The purpose of this study is to examine the changes in breast tissue, in women at high risk of breast cancer who are being treated with controlled ovarian hyperstimulation.
Interventions
- PROCEDURE RPFNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01403688
The ClinicalTrials.gov registry entry for NCT01403688 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RPFNA is the first listed.
NCT01403688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01403688 about?
NCT01403688 is a clinical study titled "Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin". Fertility drugs have the effect of increasing hormone levels. Higher hormone levels from infertility treatments may increase breast cancer risk, but there has not been enough research to know for sure. Researchers want to use a method of taking breast tissue cells from women who are having infertili...
What is the current status of trial NCT01403688?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2011-06. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01403688?
The interventions under investigation include: RPFNA (PROCEDURE).
Who is sponsoring clinical trial NCT01403688?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.